[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group].

MLA

von Minckwitz, G., et al. “[Preoperative Chemotherapy in Primary Operable Breast Cancer with a Dose-Dense Combination of Doxorubicin and Docetaxel (ADoc) - Experience of the GEPARDO-GABG Study Group].” Zentralblatt Fur Gynakologie, vol. 123, no. 9, Sept. 2001, pp. 497–504. EBSCOhost, https://doi.org/10.1055/s-2001-18222.

APA

von Minckwitz, G., Raab, G., Schütte, M., Hilfrich, J., Blohmer, J. U., Gerber, B., Costa, S. D., Merkle, E., Eidtmann, H., Lampe, D., Jackisch, C., du Bois, A., Tulusan, A. H., Gademann, G., Sinn, H. P., Caputo, A., Graf, E., & Kaufmann, M. (2001). [Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group]. Zentralblatt Fur Gynakologie, 123(9), 497–504. https://doi.org/10.1055/s-2001-18222

Chicago

von Minckwitz, G, G Raab, M Schütte, J Hilfrich, J U Blohmer, B Gerber, S D Costa, et al. 2001. “[Preoperative Chemotherapy in Primary Operable Breast Cancer with a Dose-Dense Combination of Doxorubicin and Docetaxel (ADoc) - Experience of the GEPARDO-GABG Study Group].” Zentralblatt Fur Gynakologie 123 (9): 497–504. doi:10.1055/s-2001-18222.